Heart

Fotoportretų parodoje „Tarp mūsų“ – žmonių su negalia laimė

pagal

Gegužės 8 d., antradienį, 13 val. VDU Socialinių mokslų fakultetas, Vilijampolės socialinės globos namai ir „Beautiful Heart“ fondas kviečia į fotoportretų parodos „Tarp mūsų“ atidarymą. Atidarymas vyks ir paroda bus eksponuojama VDU Socialinių mokslų fakulteto pirmojo aukšto fojė, Jonavos g. 66, Kaune. Fondo „Beautiful Heart“ vadovės Jolantos Sadauskienės inicijuotoje ir remiamoje parodoje bus eksponuojami Vilijampolės … Skaityti toliau

One Million Dollars Donated to Educate Refugee Children in Asia and MENA Region

pagal

Sharjah Ruler’s donation to a Malaysian charity to continue supporting displaced communities SHARJAH, United Arab Emirates–(BUSINESS WIRE)–A donation of USD 1 million has been given to strengthen the educational infrastructure for refugee and internally displaced children in Asia, Middle East and North Africa, at a time when according to UNHCR statistics, children represent about half … Skaityti toliau

1000 Girls in Pakistan to Receive Education through The Big Heart Foundation and Malala Fund

pagal

The Big Heart Foundation (TBHF), a global humanitarian charity based in Sharjah, UAE, is funding the second phase of a school for girls in Pakistan in keeping with its dedication to ensuring children have access to education, enabling them to contribute to the development of their communities. The project will be funded by the TBHF … Skaityti toliau

New THOMAS SABO timepieces – Studded look and retro designs as style codes for Spring/Summer 2018

pagal

Lauf/Pegnitz – THOMAS SABO presents a new generation of timepieces: Rebel at heart Women and Rebel at heart Men are two series that use avant-garde elements to point the way to the style codes for the season.   The design of the six women’s watches incorporates subtle Rock ‘n’ Roll elements: In a reflection of the … Skaityti toliau

Symetis and Boston Scientific reach USD 435 million purchase agreement

pagal

Definitive purchase agreement whereby Boston Scientific will acquire Symetis for $435 million in an all cash, up-front payment Acquisition of Symetis will expand the treatment offerings for patients with aortic valvular heart disease Acquisition projected to close during the second quarter of 2017, subject to customary closing conditions Symetis’ IPO launched on Euronext Paris and … Skaityti toliau